Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20261 analyst targets · 90 days
- Share price
- $11.00
- Average 1Y price target
- $28.75+161.36%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall1
- DCF1
- Return on equity1
- Return on assets1
- Debt / equity1
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 4 | $28.75 |
| Last year | 5 | $27.00 |
| All time | 11 | $17.70 |
Recent rating changes
The latest 39 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2026 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Aug 6, 2026 | Canaccord Genuity | maintain | Buy | Buy |
| Dec 4, 2025 | Canaccord Genuity | maintain | Buy | Buy |
| Aug 1, 2025 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Jul 16, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Jun 17, 2025 | Roth Capital | maintain | Buy | Buy |
| May 15, 2025 | Roth Capital | maintain | Buy | Buy |
| May 15, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| May 15, 2025 | Canaccord Genuity | maintain | Buy | Buy |
| May 12, 2025 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Apr 21, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Mar 21, 2025 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Mar 20, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Nov 7, 2024 | Roth MKM | maintain | Buy | Buy |
| Nov 7, 2024 | Craig-Hallum | maintain | Buy | Buy |
| Aug 8, 2024 | Roth MKM | maintain | Buy | Buy |
| Aug 8, 2024 | Craig-Hallum | maintain | Buy | Buy |
| May 8, 2024 | Craig-Hallum | maintain | Buy | Buy |
| Mar 19, 2024 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Mar 6, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Jan 10, 2024 | Roth MKM | maintain | Buy | Buy |
| Nov 9, 2023 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Oct 30, 2023 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Sep 27, 2023 | Roth MKM | maintain | Buy | Buy |
| Aug 9, 2023 | Piper Sandler | maintain | Neutral | Neutral |
| Aug 9, 2023 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| May 11, 2023 | Oppenheimer | maintain | Outperform | Outperform |
| May 11, 2023 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Mar 28, 2023 | Piper Sandler | maintain | Neutral | Neutral |
| Mar 24, 2023 | Baird | maintain | Outperform | Outperform |
| Nov 9, 2022 | Piper Sandler | maintain | Neutral | Neutral |
| Nov 9, 2022 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Aug 4, 2022 | Piper Sandler | maintain | Neutral | Neutral |
| Jul 18, 2022 | Piper Sandler | downgrade | Overweight | Neutral |
| May 5, 2022 | Piper Sandler | maintain | Overweight | Overweight |
| Feb 24, 2022 | Piper Sandler | maintain | Overweight | Overweight |
| Feb 24, 2022 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| Jan 13, 2022 | Piper Sandler | maintain | Overweight | Overweight |
| May 14, 2021 | Piper Sandler | maintain | Overweight | Overweight |